BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35960098)

  • 1. Validation of the neutrophil-to-lymphocyte ratio as a new simple biomarker of adult onset Still's disease: A STROBE-Compliant prospective observational study.
    Daghor Abbaci K; Ait Hamadouche N; Otmani F; Dahou Makhloufi C; Mechid F; Makrelouf M; Otmane A; Smail N; Boucelma M; Aissat FZ; Lefkir-Teffiani S; Bengana B; Boukheris N; Tebaibia A; Taharbouchet B; Ayoub S; Benziane B; Oumnia N; Haouichet C; Hanni F; Laraba N; Hakem D; Benfenatki N; Berrah A
    Medicine (Baltimore); 2022 Aug; 101(32):e29970. PubMed ID: 35960098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposal of a new diagnostic algorithm for adult-onset Still's disease.
    Daghor-Abbaci K; Ait Hamadouche N; Makhloufi CD; Mechid F; Otmani F; Makrelouf M; Otmane A; Smail N; Boucelma M; Aissat FZ; Lefkir-Teffiani S; Bengana B; Boukheris N; Tebaibia A; Taharbouchet B; Ayoub S; Benziane B; Oumnia N; Haouichet C; Hanni F; Laraba N; Hakem D; Benfenatki N; Berrah A
    Clin Rheumatol; 2023 Apr; 42(4):1125-1135. PubMed ID: 36694091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset Still's disease: A STROBE-compliant retrospective observational analysis.
    Seo JY; Suh CH; Jung JY; Kim AR; Yang JW; Kim HA
    Medicine (Baltimore); 2017 Jul; 96(29):e7546. PubMed ID: 28723775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Fautrel classification criteria for adult-onset Still's disease.
    Lebrun D; Mestrallet S; Dehoux M; Golmard JL; Granger B; Georgin-Lavialle S; Arnaud L; Grateau G; Pouchot J; Fautrel B
    Semin Arthritis Rheum; 2018 Feb; 47(4):578-585. PubMed ID: 28760536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and hyperferritinemia diagnostic cutoff points for AOSD based on ROC curve: a Chinese experience.
    Lian F; Wang Y; Yang X; Xu H; Liang L
    Rheumatol Int; 2012 Jan; 32(1):189-92. PubMed ID: 20798946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult-onset Still's disease: still a diagnosis of exclusion. A nested case-control study in patients with fever of unknown origin.
    Vanderschueren S; Hermans F; De Munter P; Knockaert D
    Clin Exp Rheumatol; 2012; 30(4):514-9. PubMed ID: 22510428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the international league against rheumatism classification criteria for systemic juvenile idiopathic arthritis as a prognostic factor in patients with adults-onset Still's disease.
    Yang JW; Lee E; Seo JY; Jung JY; Suh CH; Kim HA
    Pediatr Rheumatol Online J; 2018 Jan; 16(1):9. PubMed ID: 29370863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination value of biomarkers in discriminating adult onset Still's disease and sepsis.
    Zhang M; Xie M; Wang Y; Li J; Zhou J
    Wien Klin Wochenschr; 2021 Feb; 133(3-4):118-122. PubMed ID: 32430612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of clinical measures and different criteria for diagnosis of adult-onset Still's disease in a Chinese population.
    Jiang L; Wang Z; Dai X; Jin X
    J Rheumatol; 2011 Apr; 38(4):741-6. PubMed ID: 21285163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A series of 22 patients with adult-onset Still's disease presenting with fever of unknown origin. A difficult diagnosis?
    Baxevanos G; Tzimas T; Pappas G; Akritidis N
    Clin Rheumatol; 2012 Jan; 31(1):49-53. PubMed ID: 21603876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Heparin-Binding Protein as a Potential Biomarker to Distinguish Adult-Onset Still's Disease From Sepsis.
    Tian R; Chen X; Yang C; Teng J; Qu H; Liu HL
    Front Immunol; 2021; 12():654811. PubMed ID: 33868298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
    Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
    Front Immunol; 2021; 12():750114. PubMed ID: 34691064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis.
    Priori R; Colafrancesco S; Alessandri C; Minniti A; Perricone C; Iaiani G; Palazzo D; Valesini G
    J Rheumatol; 2014 Jun; 41(6):1118-23. PubMed ID: 24786926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
    Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
    Front Immunol; 2018; 9():3099. PubMed ID: 30687316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult-onset Still's disease or systemic-onset juvenile idiopathic arthritis and spondyloarthritis: overlapping syndrome or phenotype shift?
    Mitrovic S; Hassold N; Kamissoko A; Rosine N; Mathian A; Mercy G; Pertuiset E; Nocturne G; Fautrel B; Koné-Paut I
    Rheumatology (Oxford); 2022 May; 61(6):2535-2547. PubMed ID: 34559214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still's disease from sepsis.
    Koga T; Sumiyoshi R; Furukawa K; Sato S; Migita K; Shimizu T; Umeda M; Endo Y; Fukui S; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Nonaka F; Yachie A; Kondo H; Maeda T; Kawakami A
    Arthritis Res Ther; 2020 May; 22(1):108. PubMed ID: 32381117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker screening and validation for the differentiation of bloodstream infection from adult-onset Still's disease: A prospective cohort study.
    Zhang W; Yang T; Zhang H; Xu Y; Yang Q; Liu Q; Gao Y; Wu J; Shao L; Zhang W
    Cytokine; 2021 Oct; 146():155642. PubMed ID: 34325118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-derived lipocalin-2 in adult-onset Still's disease: a novel biomarker of disease activity and liver damage.
    Jia J; Yang L; Cao Z; Wang M; Ma Y; Ma X; Liu Q; Teng J; Shi H; Liu H; Cheng X; Ye J; Su Y; Sun Y; Chi H; Liu T; Wang Z; Wan L; Yang C; Hu Q
    Rheumatology (Oxford); 2021 Jan; 60(1):304-315. PubMed ID: 32766690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients.
    Gerfaud-Valentin M; Maucort-Boulch D; Hot A; Iwaz J; Ninet J; Durieu I; Broussolle C; Sève P
    Medicine (Baltimore); 2014 Mar; 93(2):91-99. PubMed ID: 24646465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic immune-inflammation index combined with ferritin can serve as a reliable assessment score for adult-onset Still's disease.
    Kim JW; Jung JY; Suh CH; Kim HA
    Clin Rheumatol; 2021 Feb; 40(2):661-668. PubMed ID: 32623648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.